Bioengineered vein: A first in U.S.

| | Cardiovascular Business | Structural Heart Disease

Vascular surgeon Jeffrey H. Lawson, MD, PhD, implanted a bioengineered vein graft June 5 in a patient with end-stage kidney disease in a two-hour procedure at Duke University Hospital in Durham, N.C. The operation launches the U.S. trial of the human cell-based product that Lawson helped develop. If the bioengineered veins prove beneficial for hemodialysis patients, then they may try to develop a graft for heart bypass surgeries.

Surgeons at Duke University Hospital implant bioengineered vein

Related Content

CMS proposes Medicare coverage for transcatheter tricuspid valve replacement
Hydra TAVR valve gains key approval as global reach continues to grow
SAVR outperforms TAVR in patients with bicuspid aortic valves
Treating AFib patients with TAVR still linked to elevated risks
Heart surgeons detail world’s first robotic heart procedure of its kind
Years of progress have made TAVR more effective when treating concomitant mitral stenosis

Around the web

Radiology Business
Key takeaways from RSNA 2024 for AI, CT, MRI and the radiology staffing shortage

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Health Imaging
New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.